Maastricht, The Netherlands – 21-Jan-2026
PEYEONEER Ophthalmic Solutions has been awarded the regional prize in the regional selection of the National Health and Innovation Award (Nationale Zorginnovatieprijs). With this achievement, PEYEONEER has secured a place among the seven national finalists competing for the prestigious national title.
The National Health and Innovation Award recognizes the most promising healthcare innovations in the Netherlands that have the potential to significantly improve patient care, accessibility, and efficiency within the healthcare system.
As a regional winner, PEYEONEER will now advance to the national finals, where it will compete alongside six other innovative healthcare companies from across the country. The finalists will present their solutions to a national jury and audience during the final event, where the overall winner of the National Health and Innovation Award will be announced.
PEYEONEER develops an advanced glaucoma implant with the goal of preventing vision loss and improving outcomes for glaucoma patients worldwide.
“We are honored to receive this regional recognition and to be selected as one of the national finalists,” said Christian Bertens, CEO of PEYEONEER. “This nomination reflects the dedication of our team and the importance of developing innovative solutions that can help detect eye diseases earlier and improve patient care.”
The National Health and Innovation Award is organized annually within the Dutch healthcare innovation ecosystem and highlights groundbreaking solutions that can strengthen the future of healthcare.
The national final will take place later this year, where the seven finalists will compete for the national award.
